HEALTH.2013.1.3-2
HEALTH.2013.1.3-2
6 projects · €33,846,175 total EU contribution (project-level) · 63 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€33,846,175
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (8)
- UK (6)
- Spain (5)
- France (5)
- IE (5)
- Italy (5)
- SE (5)
- US (4)
- DK (3)
- CH (2)
- CZ (2)
- EE (2)
- HU (2)
- AU (1)
- CA (1)
- EL (1)
- IL (1)
- LU (1)
- Netherlands (1)
- NO (1)
- PL (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AU2 projects · DK
- INSERM2 projects · FR
- AUH1 projects · DK
- Aegean Conferences,1 projects · US
- AMYNDAS PHARMACEUTICALS SINGLEMEMBER PC1 projects · EL
- ARTTIC1 projects · FR
- AVANTEA1 projects · IT
- ACS1 projects · UK
- AOUP1 projects · IT
- BACTIGUARD1 projects · SE
- BIOS1 projects · IE
- BRIGHAM INC1 projects · US
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
New approaches in the development of Hypoallergenic implant material in Orthopaedics: steps to personalised medicine HYPORTH · 602398 | FP7 | €5,282,600 | €7,207,290 | Details |
Disarming the intravascular innate immune response to improve treatment modalities for chronic kidney disease DIREKT · 602699 | FP7 | €5,984,070 | €8,362,243 | Details |
Defining the role of xeno-directed and autoimmune events in patients receiving animal-derived bioprosthetic heart valves TRANSLINK · 603049 | FP7 | €5,996,971 | €8,025,983 | Details |
Local Immunomodulation around implants by innovative auxiliary hydrogel-based systems encapsulating autologous and phenotype controlled macrophages IMMODGEL · 602694 | FP7 | €5,851,316 | €7,468,527 | Details |
Adverse Immune Signatures and their Prevention in Corneal Transplantation VISICORT · 602470 | FP7 | €5,989,491 | €7,910,150 | Details |
Nano Engineering for Cross Tolerance: new approach for bioengineered, vascularised, chimeric islet transplantation in non-immunosuppressed hosts NEXT · 602235 | FP7 | €4,741,726 | €6,103,495 | Details |